TDG$1,256.90

TransDigm shows strong multi-year growth, with revenue rising from 5.4bn to 8.8bn and TTM revenue at 10.0bn, above FY2025 and implying re-acceleration. Net income also compounded well, though TTM growth slowed sharply to 2.7% versus 21.0% in FY2025, suggesting profit conversion is less dynamic lately. Margins are excellent and broadly improving: gross margin expanded from about 57% to 60%, while operating margin moved from 41% to 47%, indicating strong pricing power and operating leverage. Earnings are generally durable, but higher interest expense and a normalizing tax rate weighed on the latest period; other income/expense is volatile but immaterial. Versus typical industrial peers, profitability is exceptional, but leverage and rising financing costs remain the main flag.

The balance sheet shows adequate near-term liquidity but weak structural quality. Cash and equivalents were $2.8 billion in FY2025, with total current assets of $7.0 billion against current liabilities of $2.2 billion, implying workable short-term coverage and healthy working capital of $4.8 billion. However, solvency remains a major concern because total liabilities reached $32.6 billion versus total assets of $22.9 billion, leaving shareholders’ equity at a deeply negative $9.7 billion. Debt is very elevated at $30.0 billion and has continued rising, while retained earnings remain significantly negative at $10.6 billion. The asset base has grown, but much of it has been funded by leverage rather than equity, creating a fragile capital structure and persistent balance sheet risk.

Cash generation has been strong overall, with operating cash flow rising from $948 million in FY2022 to $2.0 billion in FY2024, then holding roughly flat at $2.0 billion in FY2025 and improving to $2.2 billion TTM. Free cash flow also remained healthy at $1.8 billion in FY2025 and $1.9 billion TTM, even as capital spending increased from $119 million to $222 million and then $271 million TTM, suggesting continued reinvestment without weakening cash conversion. Working capital was a consistent drag, especially FY2025’s $558 million outflow, which kept CFO from growing faster. Capital allocation was active, with substantial debt issuance and repayment, plus large dividends and buybacks, but cash generation remained sufficient to absorb them.

Liquidity appears very strong on paper, with current and quick ratios remaining far above 1.0 across the period, though both were volatile and the latest readings are below prior peaks. That suggests ample short-term coverage, but not a clean upward trend. Leverage is a bigger concern: debt-to-equity is negative throughout, which points to a negative equity base and makes the ratio hard to interpret in the usual way, while the balance sheet still appears meaningfully debt-funded. Efficiency is modest, with asset turnover low but improving from 0.30 to 0.39 and holding near 0.37 TTM. Profitability is the clear strength, with gross, operating, pre-tax, and net margins all expanding, and ROA improving to solid levels despite negative ROE tied to the equity structure.

TransDigm shows a strong multi-year compounding profile, with revenue rising from 5.43B USD to 8.83B USD before analysts extend that climb to 10.50B USD and 11.56B USD. Revenue growth was very robust early, then eased in the latest actual period before re-accelerating in the first forward year and moderating again in the second, pointing to continued expansion rather than a sharp inflection. EPS has been more volatile but still trends higher, with forecast EPS growth improving in the second forward year, suggesting margin leverage after a softer transition year. Analyst sentiment is constructive: a Buy consensus, a 1350 to 1972 USD target range, and 19 analysts indicate solid coverage, while recent recommendation mixes remain mostly Buy/Hold with no negative ratings.